EXAGEN INC. - COMMON STOCK

Exagen Inc. Reports Third Quarter 2022 Results

14 11 2022 15:05:01 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

08 11 2022 15:05:02 提供 Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022

31 10 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Announces Appointment of John Aballi as CEO

17 10 2022 08:00:00 提供 Nasdaq GlobeNewswire

Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer

04 10 2022 07:25:00 提供 Nasdaq GlobeNewswire

Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting

20 9 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients

01 9 2022 15:05:01 提供 Nasdaq GlobeNewswire

Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA

04 8 2022 15:06:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Reports Second Quarter 2022 Results

04 8 2022 15:05:01 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

25 7 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

21 7 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

05 7 2022 07:25:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with MediNcrease

09 6 2022 07:25:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

26 5 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

16 5 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

11 5 2022 15:06:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2022 Results

11 5 2022 15:05:01 提供 Nasdaq GlobeNewswire

Exagen Announces Five-Week Campaign for Lupus Awareness Month

01 5 2022 11:00:00 提供 Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

25 4 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

20 4 2022 15:05:00 提供 Nasdaq GlobeNewswire